Abstract
Introduction
Marfan's syndrome is an autosomal dominant disorder of the connective tissue, caused by mutations of the gene coding fibrillin on chromosome 15 (1, 2) . Prevalence of this disease is estimated to range from 1 in 10,000 to 1 in 20,000 (1) (2) (3) (4) . The condition is characterized by musculoskeletal, cardiovascular, and ocular manifestations (1, 2, 4, 5) . Cardiovascular disorders in this condition include mitral valve prolapse, mitral regurgitation, and aortic root dilatation with aortic valve incompetence (1, 2, 5) . Aortic root dilatation and Stanford type A aortic dissection are the major causes of morbidity and mortality (5, 6) .
Pregnancy imposes substantial cardiovascular stresses such as pressure and volume overload (3) (4) (5) (6) (7) . Therefore, pregnancy in Marfan's syndrome increases the risk of aortic root dilatation and aortic dissection and seriously threatens the life of the patient (3) (4) (5) (6) (7) . We report the case of a young pregnant woman with Marfan's syndrome and mild dilatation of the aortic root, who developed postpartum abdominal aortic aneurysm followed by thoracic aortic dissection.
Case Report
The patient was a 24-year- (1, 2, 5) . Pregnancy is known to be a crucial risk factor as it imposes substantial cardiovascular stress (4) (5) (6) (7) and accelerates the development of pathologic changes in the arterial wall (6) , leading to the possibility of dilatation, dissection, and rupture of the aorta with progression of pregnancy (4) (5) (6) (7) . Dissection and rupture of the aorta carry a high risk of maternal and fetal mortality (6) ; hence, women with Marfan's syndrome with dilatation of the aortic root
F i g u r e 1 . Co mp a r i s o n o f t h e a o r t i c r o o t d u r i n g a n d a f t e r p r e g n a n c y . T r a n s t h o r a c i c e c h o c a r d i o g r a p h y s h o we d a o r t i c r o o t d i l a t a t i o n t o 4 2 mm d u r i n g p r e g n a n c y ( A) a n d 4 1 mm i n t h e p o s t p a r t u m p e r i o d ( B ) . No ma r k e d c h a n g e wa s o b s e r v e d i n t h e s i z e a n d s h a p e o f t h e a o r t i c r o o t .

height. Echocardiography revealed mild mitral regurgitation
F i g u r e 2 . E c h o g r a p h i c c h a n g e s o f t h e a b d o mi n a l a o r t a . A) T h e d i a me t e r o f t h e a b d o mi n a l a o r t a wa s 4 c m d u r i n g t h e 3 1 s t we e k o f g e s t a t i o n . B ) E i g h t mo n t h s a f t e r d e l i v e r y , t h e ma x i mu m d i a me t e r o f t h e a b d o mi n a l a o r t a i n c r e a s e d t o 8 c m, f o r mi n g a n i n f r a r e n a l s p i n d l e -s h a p e d t r u e a b d o mi n a l a o r t i c a n e u r y s m. C) E i g h t mo n t h s a f t e r d e l i v e r y , a x i a l CT i ma g e s h o ws t h e ma x i mu m d i a me t e r o f t h e a b d o mi n a l a o r t a i n c r e a s e d t o 7 9 × 7 6 mm. D) Mu l t i p l a n a r r e f o r ma t t e d c o r o n a l i ma g e o f CT r ev e a l s f o r mi n g a n i n f r a r e n a l s p i n d l e -s h a p e d t r u e a b d o mi n a l a o r t i c a n e u r y s m.
F i g u r e 3 . Hi s t o p a t h o l o g i c f i n d i n g s o f t h e r e s e c t e d a b d o mi n a l a o r t i c a n e u r y s m. A) T h e wa l l o f t h e a b d o mi n a l a o r t a s h o we d i n t i ma l t h i c k e n i n g a n d my x o i d d e g e n e r a t i o n o f t h e me d i a ( HE s t a i n , × 2 5 ) . B ) T h e wa l l s h o we d f r a g me n t a t i o n o f t h e me d i a , r e d u c t i o n a n d d i s a p p e a r a n c e o f e l a s t i c f i b e r s a n d c y s t i c me d i a l d e g e n e r a t i o n ( E l a s t i c a v a n Gi e s o n s t a i n , × 2 5 ) .
have previously been recommended to avoid pregnancy (8) .
Recently, however, new guidelines on pregnancy for women with Marfan's syndrome have been established, which indicate that women with an aortic root diameter of less than 40 mm rarely encounter serious problems (9-11). Other reports have mentioned relatively minor risk when the aortic root diameter is less than 45 mm (3). Nonetheless, debate continues regarding the aortic root diameter above which pregnancy should be discouraged in women with Marfan's syndrome. In the present case, the patient's aortic root meas-
F i g u r e 4 . A) Mu l t i p l a n a r r e f o r ma t t e d i ma g e o f c o n t r a s t -e n h a n c e d CT ( l e f t a n t e r i o r o b l i q u e v i e w) c l e a r l y s h o we d a o r t i c d i s s e c t i o n ( S t a n f o r d t y p e B ) . T h e i n t i ma l f l a p o r i g i n a t e d j u s t d i s t a l t o t h e l e f t s u b c l a v i a n a r t e r y a n d e x t e n d e d d i s t a l l y i n t o t h e t h o r a c i c a o r t a a t t h e l e v e l o f t h e p u l mon a r y t r u n k . B ) Co n t r a s t -e n h a n c e d CT a x i a l i ma g e o f t h e c h e s t a t t h e l e v e l o f t h e a o r t o -p u l mo n a r y wi n d o w s h o we d a n i n t i ma l f l a p s e p a r a t i n g t h e t r u e a n d f a l s e l u mi n a o f a n a o r t i c d i s s e c t i o n o f t h e d e s c e n d i n g t h o r a c i c a o r t a .
ured 42 mm at the beginning of pregnancy. Although we strongly recommended termination of pregnancy according to the existing guidelines (9) (10) (11) , the patient and her family were eager to continue the pregnancy. Fortunately the patient did not develop enlargement of the aortic root and uneventfully delivered a female child by cesarean section.
The most serious pregnancy-related complication in Marfan's syndrome is aortic dissection, most of which involve the ascending aorta (3, 4, 6) . The complication of Stanford type B dissection can also develop before and during delivery, however, it rare for this to develop after delivery (3, 4, 6, 12 (11, 16, 17) . Controversy exists regarding the teratogenic effects of β-blockers in the peripartum period. Some studies show that β-blockers are not teratogenic (18) , and others mention that even long-term treatment with β-blockers is safe (16, 19) . According to these reports, the use of β-blockers is recommended during pregnancy in Marfan's syndrome (10, 11, 17, 20) . However, studies have reported lower birth weight in association with exposure to atenolol during gestation (21) and the excretion of β-blockers in breast milk (22 
